PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.78%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
0.79%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
-4.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.66%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.66%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.66%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 3141.T stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.86%
10Y revenue/share CAGR 1.25-1.5x 3141.T's 71.33%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
82.86%
5Y revenue/share CAGR 1.25-1.5x 3141.T's 71.33%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
63.59%
3Y revenue/share CAGR above 1.5x 3141.T's 20.43%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
OCF/share CAGR of 100.00% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
100.00%
OCF/share CAGR of 100.00% while 3141.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
100.00%
3Y OCF/share CAGR of 100.00% while 3141.T is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
201.34%
Net income/share CAGR at 75-90% of 3141.T's 234.33%. Bill Ackman would press for strategic moves to boost long-term earnings.
201.34%
5Y net income/share CAGR at 75-90% of 3141.T's 234.33%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
123.76%
3Y net income/share CAGR 1.25-1.5x 3141.T's 88.89%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
126.65%
Equity/share CAGR of 126.65% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
126.65%
Equity/share CAGR of 126.65% while 3141.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
85.78%
3Y equity/share CAGR above 1.5x 3141.T's 36.04%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.86%
Firm’s AR is declining while 3141.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.86%
Inventory is declining while 3141.T stands at 24.15%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.20%
Negative asset growth while 3141.T invests at 11.61%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.97%
1.25-1.5x 3141.T's 3.25%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-22.28%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.48%
SG&A growth of 1.48% while 3141.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.